Gastroenterology Unit IRCCS "Casa Sollievo della Sofferenza" Hospital, Viale dei Cappuccini n.1, 71013 San Giovanni Rotondo, Italy.
PPAR Res. 2012;2012:560846. doi: 10.1155/2012/560846. Epub 2012 Sep 17.
Nowadays, the study of the peroxisome proliferators activated receptors (PPARs) as potential targets for cancer prevention and therapy has gained a strong interest. From a biological point of view, the overall responsibility of PPARs in cancer development and progression is still controversial since several studies report both antiproliferative and tumor-promoting actions for these signaling molecules in human cancer cells and animal models. In this paper, we discuss PPARs functions in the context of different types of gastrointestinal cancer.
如今,过氧化物酶体增殖物激活受体(PPARs)作为癌症预防和治疗的潜在靶点的研究引起了强烈关注。从生物学角度来看,PPARs 在癌症发展和进展中的总体责任仍然存在争议,因为一些研究报告称这些信号分子在人类癌细胞和动物模型中既有抗增殖作用又有促进肿瘤作用。本文讨论了 PPARs 在不同类型胃肠道癌中的作用。